X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (93) 93
rheumatology (61) 61
male (60) 60
female (58) 58
middle aged (57) 57
index medicus (50) 50
adult (45) 45
aged (35) 35
rheumatoid arthritis (24) 24
treatment outcome (20) 20
arthritis (18) 18
arthritis, rheumatoid - drug therapy (18) 18
immunology (18) 18
antirheumatic agents - therapeutic use (17) 17
disease (16) 16
rheumatoid-arthritis (15) 15
severity of illness index (14) 14
medicine & public health (12) 12
research article (12) 12
tumor necrosis factor-alpha - antagonists & inhibitors (12) 12
diagnosis (11) 11
disease-activity (11) 11
drug therapy, combination (11) 11
infliximab (11) 11
animals (10) 10
arthritis, rheumatoid - immunology (10) 10
classification (10) 10
systemic lupus erythematosus (10) 10
therapy (10) 10
abridged index medicus (9) 9
drug therapy (9) 9
expression (9) 9
internal medicine (9) 9
patients (9) 9
prospective studies (9) 9
antibodies, monoclonal - therapeutic use (8) 8
care and treatment (8) 8
medical research (8) 8
nephritis (8) 8
research (8) 8
rheumatoid factor (8) 8
ultrasonography (8) 8
analysis (7) 7
apoptosis (7) 7
criteria (7) 7
disease activity (7) 7
inflammation (7) 7
lupus erythematosus, systemic - drug therapy (7) 7
medicine, experimental (7) 7
medicine, general & internal (7) 7
methotrexate (7) 7
musculoskeletal diseases (7) 7
reproducibility of results (7) 7
scleroderma, systemic - complications (7) 7
studies (7) 7
systemic-lupus-erythematosus (7) 7
t cells (7) 7
time factors (7) 7
adolescent (6) 6
arthritis, rheumatoid - complications (6) 6
austria (6) 6
cells, cultured (6) 6
double-blind (6) 6
double-blind method (6) 6
immunosuppressive agents - therapeutic use (6) 6
lupus erythematosus, systemic - immunology (6) 6
medical colleges (6) 6
mice (6) 6
pilot projects (6) 6
psoriatic arthritis (6) 6
quality of life (6) 6
remission induction (6) 6
rheumatism (6) 6
risk-factors (6) 6
skin and connective tissue diseases (6) 6
tumor necrosis factor-alpha - immunology (6) 6
tumor-necrosis-factor (6) 6
vitamin d (6) 6
aged, 80 and over (5) 5
antirheumatic agents - adverse effects (5) 5
arthritis, rheumatoid - diagnosis (5) 5
autoimmune diseases (5) 5
biochemistry & molecular biology (5) 5
comparative analysis (5) 5
early rheumatoid-arthritis (5) 5
follow-up studies (5) 5
lupus erythematosus, systemic - therapy (5) 5
medicine/public health, general (5) 5
monoclonal-antibody (5) 5
open-label (5) 5
orthopedics (5) 5
regulatory t cells (5) 5
retrospective studies (5) 5
safety (5) 5
scleroderma (5) 5
surveys and questionnaires (5) 5
young adult (5) 5
1,25-dihydroxyvitamin d-3 (4) 4
1506 (4) 4
american-college (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2016, Volume 75, Issue 1, pp. 3 - 15
Journal Article
Molecules, ISSN 1420-3049, 01/2017, Volume 22, Issue 1, p. 134
A disruption of the crucial balance between regulatory T-cells (Tregs) and Th17-cells was recently implicated in various autoimmune disorders. Tregs are... 
Autoimmunity | Foxp3 | Regulatory T-Cells | Th17-cells | Rorγt | COLLAGEN-INDUCED ARTHRITIS | ROR-GAMMA-T | SARILUMAB PLUS METHOTREXATE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PATHOGENIC T(H)17 CELLS | regulatory T-cells | CHEMISTRY, MULTIDISCIPLINARY | ACTIVE PSORIATIC-ARTHRITIS | GROWTH-FACTOR-BETA | autoimmunity | TRANSCRIPTION FACTOR FOXP3 | RORt | PLACEBO-CONTROLLED TRIAL | ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY | Forkhead Transcription Factors - immunology | Nuclear Receptor Subfamily 1, Group F, Member 3 - antagonists & inhibitors | Humans | Interleukin-17 - immunology | Antibodies, Monoclonal - therapeutic use | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Autoimmune Diseases - genetics | Th17 Cells - drug effects | Forkhead Transcription Factors - antagonists & inhibitors | Pyrroles - therapeutic use | Autoimmune Diseases - pathology | Autoimmune Diseases - drug therapy | Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics | Th17 Cells - pathology | Nuclear Receptor Subfamily 1, Group F, Member 3 - immunology | Signal Transduction | Autoimmune Diseases - immunology | Gene Expression Regulation | Interleukin-17 - genetics | Inflammation | Forkhead Transcription Factors - genetics | Ustekinumab - therapeutic use | T-Lymphocytes, Regulatory - drug effects | Animals | Interleukin-17 - antagonists & inhibitors | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Th17 Cells - immunology | Immunologic Factors - therapeutic use | Disruption | Maintenance | Autoimmune diseases | Disorders | RORγt
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2014, Volume 73, Issue 6, pp. 958 - 967
Journal Article
PLOS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, p. e0172056
Objectives In Primary Sjögren’s Syndrome (PSS), there is an apparent lack of data concerning the perspectives of patients, their needs, preferences and... 
Lupus | Qualitative research | Sjogren's syndrome | Internal medicine | Rheumatology | Clinical trials | Fatigue | Data processing | Focus groups | Patients | Quality of life | Medicine | Studies | Immunology | Pain | Rheumatoid arthritis | Rheumatism | Occupational therapy | Constipation | Interviews
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 2014, Volume 16, Issue 5, pp. 476 - 476
Introduction: This study was performed to develop ultrasound composite scores for the assessment of inflammatory and structural lesions in Psoriatic Arthritis... 
Sensitivity to change | Both new PsA ultrasound composite scores (PsASon22 and PsASon13) revealed sufficient convergent construct validity | Reliability and feasibility | CLINICAL REMISSION | DIAGNOSIS | EARLY RHEUMATOID-ARTHRITIS | GOUT | DOPPLER ULTRASONOGRAPHIC ASSESSMENT | RHEUMATOLOGY | SONOGRAPHIC ASSESSMENT | CALCIUM PYROPHOSPHATE | JOINT INFLAMMATION | DISEASE-ACTIVITY | SYNOVITIS | Bone and Bones - pathology | Inflammation - pathology | Prospective Studies | Follow-Up Studies | Outcome Assessment (Health Care) | Tendons - drug effects | Humans | Middle Aged | Synovial Membrane - pathology | Male | Synovial Membrane - drug effects | Methotrexate - therapeutic use | Bone and Bones - drug effects | Feasibility Studies | Arthritis, Psoriatic - pathology | Time Factors | Inflammation - drug therapy | Tendons - diagnostic imaging | Arthritis, Psoriatic - drug therapy | Bone and Bones - diagnostic imaging | Adult | Female | Surveys and Questionnaires | Inflammation - diagnostic imaging | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Sulfasalazine - therapeutic use | Synovial Membrane - diagnostic imaging | Reproducibility of Results | Joints - drug effects | Joints - diagnostic imaging | Joints - pathology | Ultrasonography, Doppler - methods | Tendons - pathology | Arthritis, Psoriatic - diagnostic imaging | Isoxazoles - therapeutic use | Medicine, Experimental | Medical research | Research | Psoriatic arthritis
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2017, Volume 76, Issue 3, pp. 554 - 561
Journal Article